Paediatric Gastrointestinal, Hepatic and Pancreatic Inflammatory Myofibroblastic Tumours, A Single Centre Experience
Sign Up to like & getrecommendations! Published in 2021 at "Journal of Pediatric Gastroenterology and Nutrition"
DOI: 10.1097/mpg.0000000000003311
Abstract: ABSTRACT Inflammatory myofibroblastic tumours (IMTs) are rare soft tissue tumours. Reports of gastrointestinal tract, liver and pancreas tumours are limited. The objective of this study is to identify presenting features, contributing prognostic / etiological factors… read more here.
Keywords: inflammatory myofibroblastic; gastrointestinal hepatic; paediatric gastrointestinal; treatment ... See more keywords
Gastrointestinal and Hepatic Manifestations in Patients with Generalised Pustular Psoriasis.
Sign Up to like & getrecommendations! Published in 2023 at "Experimental dermatology"
DOI: 10.1111/exd.14766
Abstract: Generalised pustular psoriasis (GPP) is a rare and severe form of pustular psoriasis. It is defined by persisting or relapsing macroscopically visible sterile primary pustules occurring on non-acral skin and not within psoriasis plaques. Due… read more here.
Keywords: generalised pustular; hepatic manifestations; gpp; pustular psoriasis ... See more keywords
Gastrointestinal, hepatic, and pancreatobiliary involvement by plasma cell neoplasms: clinicopathologic correlations in a retrospective cohort of 116 cases
Sign Up to like & getrecommendations! Published in 2022 at "Histopathology"
DOI: 10.1111/his.14778
Abstract: Plasma cell neoplasms (PCNs) may involve the gastrointestinal (GI) tract in two forms: plasmacytoma (PC), an isolated lesion that lacks marrow involvement, and extramedullary myeloma (EMM). However, previous literature on PCNs involving the GI tract,… read more here.
Keywords: hepatic pancreatobiliary; cell neoplasms; gastrointestinal hepatic; plasma cell ... See more keywords
Risk of gastrointestinal and hepatic toxicities in patients with cancer treated with regorafenib: A systematic review and meta- analysis of randomized controlled trials.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e22118
Abstract: e22118Background: Regorafenib is an oral small molecule inhibitor of multiple tyrosine kinases, including VEGFR, KIT, RET, RAF1, BRAF as well as PDGFR and FGFR, and is proven to be beneficial in di... read more here.
Keywords: toxicities patients; patients cancer; gastrointestinal hepatic; hepatic toxicities ... See more keywords
[Gastrointestinal and hepatic manifestations of COVID-19 in children].
Sign Up to like & getrecommendations! Published in 2020 at "Revista chilena de pediatria"
DOI: 10.32641/rchped.vi91i4.2484
Abstract: SARS-CoV-2 is a high environmental stable virus. It is predominantly a respiratory pathogen that also affects the gastrointestinal tract. The ACE 2 receptor is the main receptor of SARS-CoV-2, with evidence of its high presence… read more here.
Keywords: gastrointestinal hepatic; manifestations covid; covid children; receptor ... See more keywords
Herbal therapies in gastrointestinal and hepatic disorders: An evidence-based clinical review
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2022.962095
Abstract: The gastrointestinal tract (GIT) and the liver constitute the major organs of the human body. Indeed, the very survival of the human body depends on their proper functioning. Because the GIT is a huge and… read more here.
Keywords: git liver; review; hepatic disorders; evidence based ... See more keywords